BetterScholar BetterScholar
Title Claps Level Year L/Y
Genomic and clinical predictors of lacosamide response in refractory epilepsies
29 auth. S. Heavin, M. McCormack, S. Wolking, Lisa Slattery, N. Walley, A. Avbersek, J. Novy, S. Sinha, R. Radtke, C. Doherty, P. Auce, J. Craig, Michael R. Johnson, B. Koeleman, R. Krause, ... W. Kunz, A. Marson, T. O’Brien, Josemir W Sander, G. Sills, H. Stefánsson, P. Striano, F. Zara, C. Depondt, S. Sisodiya, D. Goldstein, H. Lerche, G. Cavalleri, N. Delanty
Clinical and genetic predictors of response to antiepileptic drugs (AEDs) are largely unknown. We examined predictors of lacosamide response in a real‐world clinical setting.
Clinical and genetic predictors of response to antiepileptic drugs (AEDs) are largely unknown. We examined predictors of lacosamide response in a real‐world clinical setting.
Published in Epilepsia Open
2
3 2019